News

Deal Announcements

Complexa Raises $4 Million Venture Capital Debt

Wednesday, June 17, 2015 5:46:00 AM PDT | VentureDeal
   Pittsburgh, Pennsylvania  --  Biotechnology company Complexa has secured $4 million in new debt investment, according to an SEC regulatory filing.

Complexa is "researching and developing and endogenous human cell signaling treatments for fibrosis and inflammation related diseases."

Investors were not disclosed, nor was how the company intends to use the proceeds.

The company was founded in 2007 and is concluding four Phase 1 trials of its lead candidate CXA-10.

Complexa is still seeking $1 million in additional financing, according to the filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1